Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Celgene Corporation

Below is an extended Celgene Corporation news listing. Click here to return to the Celgene Corporation main Biocorporate entry.

BioNews Results for Celgene Corporation:
News and FDA Updates for Celgene (NASDAQ:CELG), Genzyme (Nasdaq:GENZ) American Chronicle: Nov 16 2009 12:51AM Matching: celgene
Celgene Corporation to Present at the Lazard Capital Markets 6th Annual Healthcare Conference Pharma Live: Nov 14 2009 10:40PM Matching: celgene
Maxygen Buying Back Stock; Analysts Say No Trend Here BioWorld: Nov 14 2009 6:06AM Matching: celgene
More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st Pharma Live: Nov 13 2009 11:11PM Matching: celgene
More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st Therapeutics Daily: Nov 12 2009 5:02AM Matching: celgene
Generics firms call Big Pharma anticompetitive FiercePharma: Nov 12 2009 5:52PM Matching: celgene
Generic-Drug Makers Protest Supply Limits Wall Street Journal Online: Nov 12 2009 2:33AM Matching: celgene
More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st Genetic Engineering News: Nov 11 2009 1:19PM Matching: celgene
Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High Journal of Clinical Oncology: Nov 11 2009 8:39PM Matching: celgene
More Than 200 Abstracts Evaluating Celgene (CELG) Products across a Range of Indications to Be Presented at th BioSpace: Nov 11 2009 7:43PM Matching: celgene
Cramers 8 Picks for Cancer's Cure Cafepharma: Nov 9 2009 4:55PM Matching: celgene
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone Healthcare Sales & Marketing Network: Nov 8 2009 7:33PM Matching: celgene
New Options for Treatment of RA and Lupus are Focus of Rheumatology Thought Leader Panel PR Newswire: Nov 6 2009 7:18PM Matching: celgene
New Options for Treatment of RA and Lupus are Focus of Rheumatology Thought Leader Panel NewsBlaze: Nov 6 2009 3:48PM Matching: celgene
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone SmartBrief: Nov 5 2009 4:44PM Matching: celgene

«Celgene Corporation

This page contained an extended Celgene Corporation news listing. Click here to return to the Celgene Corporation main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.